Request Legal Help Now - Free


Zofran Faces More Birth Defects Claims

. By
New Orleans, LAAnother Zofran birth defects claim has been filed in court, alleging women who took Zofran while pregnant gave birth to infants with birth defects. The most recent Zofran lawsuit was filed against GlaxoSmithKline and alleges the company marketed Zofran off-label and knew there were risks for pregnant women associated with the anti-nausea medication but failed to warn about those risks.

According to court documents filed in the lawsuit, which involves claims from two plaintiffs, Zofran is only approved to treat severe nausea in cancer patients undergoing chemotherapy and radiation. Despite this, GlaxoSmithKline allegedly marketed Zofran off-label as a safe treatment for nausea and vomiting linked to pregnancy. (Although it is not illegal for doctors to prescribe medications off-label, it is illegal for drug companies to market their medications for unapproved uses.)

“GSK engaged in this ‘off-label’ marketing despite never having conducted a single study on the effects of Zofran on pregnant women or their unborn children,” the lawsuit alleges.
“GSK chose not to study Zofran in pregnant women or seek FDA approval before marketing the drug for treatment during pregnancy.”

Despite not testing the drug on pregnant women, the lawsuit alleges GSK knew there was a risk thanks to animal studies from the 1980s that suggested use of Zofran was linked to intrauterine deaths or malformations. Furthermore, the studies reportedly suggested that Zofran’s active ingredient could cross the placental barrier and expose fetuses to the drug.

By 2000, the lawsuit alleges, GSK knew of 32 reports of birth defects associated with Zofran and has reportedly received more reports since. The lawsuit claims GSK did not share information about these studies or potential risks with physicians or with pregnant women.

In 2012, GSK settled claims brought by the US Department of Justice that the company improperly marketed its drug for off-label uses. Among the charges GSK pled guilty to were marketing Zofran for unapproved uses; making false and unsubstantiated claims about the safety and efficacy of Zofran when used for pregnancy-related nausea; and illegally compensating health care professionals for prescribing and promoting Zofran.

The birth defects lawsuit argues that inadequate testing on GSK’s part showed a “callous, reckless, and willful indifference to the health, safety and welfare of pregnant women and their unborn children.”

The plaintiffs in the case allege their children were born with defects including ventricular septal defect, atrial septal defect and ventricular arrhythmia.

The lawsuit is Coughlin and Swann v. GlaxoSmithKline, case number 15-1815, in the US District Court for the Western District of Louisiana.


Zofran Birth Defect Legal Help

If you or a loved one have suffered losses in this case, please click the link below and your complaint will be sent to a drugs & medical lawyer who may evaluate your Zofran Birth Defect claim at no cost or obligation.


Posted by

I had a daughter and was very nauseous at the end of my pregnancy and my daughter was only born with a Hole in her but she also had cerebral palsy so it was a big huge responsibility to care and as a single mom with a disabled child in and out of the hospital she had numerous surgeries this very hard I couldn't work because I had to take care of my daughter. I was never warned about the defects it could've cause so yes it ruined my life and my daughter's life!


Fields marked * are mandatory. Please read our comment guidelines before posting.


Note: Your name will be published with your comment.

*Email Address:

Your email will only be used if a response is needed.
*Your Comment:

Are you the defendant or a subject matter expert on this topic with an opposing viewpoint? We'd love to hear your comments here as well, or if you'd like to contact us for an interview please submit your details here.

Click to learn more about

Request Legal Help Now! - Free